FDA deadlocked on asthma drug risks
Wednesday, December 10, 2008 - 17:37
in Health & Medicine
(AP) -- Deadlocked over the risks of long-acting asthma drugs, government health officials Wednesday asked outside advisers if four medications used by millions of patients should remain on the market.